EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors

Colleen B McGrath iD, Alaina H Shreves iD, Megan R Shanahan, Hannah E Guard, Manelisi V Nhliziyo, Claire H Pernar, Kathryn L Penney, Tamara L Lotan, Michelangelo Fiorentino, Lorelei A Mucci, Konrad H Stopsack iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35279 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Colleen B McGrath und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Prostate Cancer Foundation, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common somatic alteration in primary prostate cancer is the TMPRSS2:ERG gene fusion, which may be caused or promoted by distinct etiologic factors. The objective of this systematic review was to assess epidemiologic evidence on etiologic factors for prostate cancer by tumor TMPRSS2:ERG fusion status in human populations. Of 3071 publications identified, 19 cohort or case–control studies from six distinct study populations were included in this systematic review. Etiologic factors included germline genetic variants, circulating hormones, and dietary and lifestyle factors. Taller height, higher total and free testosterone levels, and fewer trinucleotide repeats in AR were possibly associated with higher risk of TMPRSS2:ERG ‐positive prostate cancer. Excess body weight, greater vigorous physical activity, higher lycopene intake, and the use of calcium channel blockers were associated with lower risk of TMPRSS2:ERG ‐positive prostate cancer. Diabetes and family history of prostate cancer were associated with both TMPRSS2:ERG ‐positive and TMPRSS2:ERG ‐negative prostate cancer. Prostate cancer germline variants had suggestive differential associations with TMPRSS2:ERG ‐positive or TMPRSS2:ERG ‐negative prostate cancer. However, results were based on few distinct study populations and generally had low precision, underscoring the need for replication. In conclusion, prostate cancer with TMPRSS2:ERG fusion is an etiologically distinct subtype that may be, in part, preventable by addressing modifiable and hormonally acting etiologic factors that align with the established mechanistic role of TMPRSS2:ERG in androgen, insulin, antioxidant, and growth factor pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsOncogene Proteins, FusionHumansMaleRisk FactorsTranscriptional Regulator ERGGenetic Predisposition to DiseaseSerine Endopeptidases

Stichwörter der Autor:innen

TMPRSS2:ERGetiologygene fusionprostate cancersystematic review

Substanzen

Oncogene Proteins, FusionTMPRSS2-ERG fusion protein, humanTMPRSS2 protein, humanTranscriptional Regulator ERGSerine Endopeptidases

Autor:innen und Institutionen

  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

ORCID-Profile: Colleen B McGrath, Alaina H Shreves, Konrad H Stopsack

Förderung

  • NCI NIH HHS
  • Prostate Cancer Foundation
  • National Cancer Institute

Zitieren

APA

McGrath, C. B., Shreves, A. H., Shanahan, M. R., Guard, H. E., Nhliziyo, M. V., Pernar, C. H., Penney, K. L., Lotan, T. L., Fiorentino, M., Mucci, L. A., & Stopsack, K. H. (2025). Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors. International Journal of Cancer. https://doi.org/10.1002/ijc.35279

Vancouver

McGrath CB, Shreves AH, Shanahan MR, Guard HE, Nhliziyo MV, Pernar CH, et al. Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors. International Journal of Cancer. 2025. doi:10.1002/ijc.35279

BibTeX
@article{McGrath2025,
  author = {McGrath, Colleen B and Shreves, Alaina H and Shanahan, Megan R and Guard, Hannah E and Nhliziyo, Manelisi V and Pernar, Claire H and Penney, Kathryn L and Lotan, Tamara L and Fiorentino, Michelangelo and Mucci, Lorelei A and Stopsack, Konrad H},
  title = {Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35279}
}
Kostenlos starten →